Janus Henderson Group PLC Celldex Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 25,642 shares of CLDX stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,642
Previous 25,922
1.08%
Holding current value
$1.06 Million
Previous $1.09 Million
12.7%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$333 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$154 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$140 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$137 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.93B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...